[HTML][HTML] Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers
G Mauri, E Jachetti, B Comuzzi, M Dugo, I Arioli… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Osteopontin (OPN) is a secreted glycoprotein, that belongs to the non-structural extracellular
matrix (ECM), and its over expression in human prostate cancer has been associated with …
matrix (ECM), and its over expression in human prostate cancer has been associated with …
[PDF][PDF] Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers
G Mauri, E Jachetti, B Comuzzi, M Dugo, I Arioli… - academia.edu
Osteopontin (OPN) is a secreted glycoprotein, that belongs to the non-structural extracellular
matrix (ECM), and its over expression in human prostate cancer has been associated with …
matrix (ECM), and its over expression in human prostate cancer has been associated with …
Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers
G Mauri, E Jachetti, B Comuzzi, M Dugo, I Arioli… - …, 2016 - ricerca.unich.it
Osteopontin (OPN) is a secreted glycoprotein, that belongs to the non-structural extracellular
matrix (ECM), and its over expression in human prostate cancer has been associated with …
matrix (ECM), and its over expression in human prostate cancer has been associated with …
Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers.
G Mauri, E Jachetti, B Comuzzi, M Dugo, I Arioli… - Oncotarget, 2016 - europepmc.org
Osteopontin (OPN) is a secreted glycoprotein, that belongs to the non-structural extracellular
matrix (ECM), and its over expression in human prostate cancer has been associated with …
matrix (ECM), and its over expression in human prostate cancer has been associated with …
Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers
G Mauri, E Jachetti, B Comuzzi, M Dugo… - …, 2016 - pubmed.ncbi.nlm.nih.gov
Osteopontin (OPN) is a secreted glycoprotein, that belongs to the non-structural extracellular
matrix (ECM), and its over expression in human prostate cancer has been associated with …
matrix (ECM), and its over expression in human prostate cancer has been associated with …
[PDF][PDF] Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers
G Mauri, E Jachetti, B Comuzzi, M Dugo, I Arioli… - pdfs.semanticscholar.org
Osteopontin (OPN) is a secreted glycoprotein, that belongs to the non-structural extracellular
matrix (ECM), and its over expression in human prostate cancer has been associated with …
matrix (ECM), and its over expression in human prostate cancer has been associated with …
[HTML][HTML] Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers
G Mauri, E Jachetti, B Comuzzi, M Dugo, I Arioli… - Oncotarget, 2015 - oncotarget.com
Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from
adenocarcinoma to aggressive human-like neuroendocrine cancers | Oncotarget Online …
adenocarcinoma to aggressive human-like neuroendocrine cancers | Oncotarget Online …
[PDF][PDF] Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers
G Mauri, E Jachetti, B Comuzzi, M Dugo, I Arioli… - iris.unipa.it
Osteopontin (OPN) is a secreted glycoprotein, that belongs to the non-structural extracellular
matrix (ECM), and its over expression in human prostate cancer has been associated with …
matrix (ECM), and its over expression in human prostate cancer has been associated with …
Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers.
G Mauri, E Jachetti, B Comuzzi, M Dugo, I Arioli… - Oncotarget, 2016 - europepmc.org
Osteopontin (OPN) is a secreted glycoprotein, that belongs to the non-structural extracellular
matrix (ECM), and its over expression in human prostate cancer has been associated with …
matrix (ECM), and its over expression in human prostate cancer has been associated with …
[PDF][PDF] Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers
G Mauri, E Jachetti, B Comuzzi, M Dugo, I Arioli… - ricerca.unich.it
Osteopontin (OPN) is a secreted glycoprotein, that belongs to the non-structural extracellular
matrix (ECM), and its over expression in human prostate cancer has been associated with …
matrix (ECM), and its over expression in human prostate cancer has been associated with …